SAN DIEGO, Nov. 4, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable informa

REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (Foamix or the Company), a specialty pharmaceutical company, announced today the peer review publication of the long term open label safety portions of studies FX2014-04 and FX2014-05 (Studies 04 & 05) in the

BRIDGEWATER, N.J., Nov. 4, 2019 /PRNewswire/ -- Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it has purchased G&W Laboratories' finished dosage manufacturing plant located in Lincolnton, NC."The purchase of the

NEW YORK, Nov. 4, 2019 /PRNewswire/ -- CannRx, a company developing proprietary, scientifically based medical and recreational products, today announced that the Company's Founder and Chief Scientific Offi

BOSTON, Nov. 4, 2019 /PRNewswire/ -- Entrada Therapeutics, a biotechnology company dedicated to transforming the treatment of devastating diseases through the intracellular delivery of biologics, today announced the appointment of Nathan J. Dowden as Chief Operating Officer. Mr. Dowden was most recently Senior Vice President of Strateg

WALTHAM, Mass., Nov. 4, 2019 /PRNewswire/ -- Fresenius Medical Care North America's Renal Therapies Group, the leading provider of kidney care products, today announced the

PRAGUE, Nov. 4, 2019 /PRNewswire/ -- RAFA 2019 – A new, validated ion chromatography tandem mass spectrometry (IC-MS/MS) analytical workflow is designed to enable food testing laboratories to overcome the challenges associated with liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis of polar anionic pesticides in complex sample matrices.

SCHLIEREN, Switzerland, Nov. 4, 2019 /PRNewswire/ -- InSphero AG today announced the company received an award at the 2019

BOSTON, Nov. 4, 2019 /PRNewswire/ -- CereVasc, LLC, a company focused on improving the treatment of communicating hydrocephalus patients, announced today that Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) approved the Company's request to conduct a clinical study titled "Endovascular Treatment of Communic

NEW YORK, Nov. 4, 2019 /PRNewswire/ -- The Beard Club (www.thebeardclub.com), a leading brand for men's grooming needs, today announced a partnership with No-Shave November, a web-bas